Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

50.0%

5 terminated/withdrawn out of 10 trials

Success Rate

44.4%

-42.1% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 recruiting1 with results4 withdrawn

Enrollment Performance

Analytics

Phase 1
6(66.7%)
Early Phase 1
2(22.2%)
N/A
1(11.1%)
9Total
Phase 1(6)
Early Phase 1(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT03325855Recruiting

Fecal Microbiota Transplant National Registry

Role: collaborator

NCT03928808Early Phase 1Withdrawn

Fecal Microbiota Transplantation (FMT) in Treatment of Severe and Enduring Anorexia Nervosa

Role: collaborator

NCT02636647Phase 1Completed

Fecal Transplant in Recurrent Hepatic Encephalopathy

Role: collaborator

NCT04373252Phase 1Withdrawn

FMT as a Treatment for Severe Motility Disorder

Role: collaborator

NCT03152188Phase 1Completed

Oral Fecal Transplant in Cirrhosis

Role: collaborator

NCT03416751Phase 1Completed

Fecal Microbial Transplant for Alcohol Misuse in Cirrhosis

Role: collaborator

NCT02847481Phase 1Completed

A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBS

Role: collaborator

NCT03527056Early Phase 1Withdrawn

Pilot Study Using Oral Capsule FMT to Decolonize GI CRE

Role: collaborator

NCT02782325Phase 1Terminated

Safety and Efficacy of Fecal Microbiome Transplantation (FMT) in the Treatment of Antibiotic Dependent Pouchitis (ADP)

Role: collaborator

NCT02968511Not ApplicableWithdrawn

EGESTA - Emergent GI Therapy for Severe, Complicated CDI Using Fecal Microbiota Transplant

Role: collaborator

All 10 trials loaded